{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:27:20Z","timestamp":1779895640944,"version":"3.53.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81\u00a0971\u00a0990"],"award-info":[{"award-number":["81\u00a0971\u00a0990"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82\u00a0172\u00a0326"],"award-info":[{"award-number":["82\u00a0172\u00a0326"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Excellent Technology Leader in Shanghai","award":["20XD1434500"],"award-info":[{"award-number":["20XD1434500"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:label\/>\n                  <jats:p>The present study collected 280 isolates of Cryptococcus neoformans and 22 isolates of Cryptococcus gattii and evaluated the consistencies between Sensititre YeastOne (SYO), VITEK 2, and the reference broth microdilution (BMD) method for the antifungal susceptibility testing of fluconazole, voriconazole, and flucytosine. For amphotericin B, SYO was replaced with the BIO KONT amphotericin B microbroth dilution kit. The essential agreements (EAs) by SYO and VITEK 2 for C. neoformans var. grubii and C. neoformans var. neoformans were 98.15\u201399.63% and 88.89\u2013100%, respectively, with fluconazole, voriconazole, and flucytosine. The EA for C. gattii VG\u00a0\u2160 against fluconazole was 29.41% by VITEK 2, while the other EAs for C. gattii strains were 100% by SYO and VITEK 2. The categorical agreements (CAs) by SYO and VITEK 2 for C. neoformans and C. gattii were 94.12\u2013100%, while VITEK 2 failed to distinguish 5\/6 fluconazole-resistant non-wild-type C. neoformans var. grubii isolates; this finding confirmed the limitation of testing fluconazole against C. neoformans as documented in the manufacturer's package insert. The EAs for amphotericin B were 97.42\u2013100% for C. neoformans and C. gattii, but the CAs were 17.65\u201360% by BIO KONT and VITEK 2. Thus, SYO can be used for susceptibility testing of C. neoformans and C. gattii against fluconazole, voriconazole, and flucytosine, and VITEK 2 can be used for susceptibility testing of C. neoformans against voriconazole and flucytosine. Further studies using amphotericin B-resistant isolates are required to assess the agreement between VITEK 2, BIO KONT, and BMD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Lay Summary<\/jats:title>\n                  <jats:p>Sensititre YeastOne showed a good agreement with the CLSI broth microdilution method for C. neoformans and C. gattii against voriconazole and flucytosine. The limitation regarding fluconazole testing against C. neoformans documented in VITEK 2 manufacturer's package insert was confirmed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mmy\/myac009","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T12:11:28Z","timestamp":1643285488000},"source":"Crossref","is-referenced-by-count":5,"title":["Comparative evaluation of Sensititre YeastOne and VITEK 2 against the Clinical and Laboratory Standards Institute M27-E4 reference broth microdilution method for the antifungal susceptibility testing of <i>Cryptococcus neoformans and Cryptococcus gattii<\/i>"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4467-618X","authenticated-orcid":false,"given":"Min","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, 200120, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, 200120, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, 200120, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, 200120, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, 200120, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Guangxi Academy of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region, 530021, Guangxi Zhuang Autonomous Region, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, 200120, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, 200120, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"2022030501115573800_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-0034-1372342","article-title":"New approaches to the diagnosis and treatment of cryptococcal meningitis","volume":"34","author":"Makadzange","year":"2014","journal-title":"Semin Neurol"},{"key":"2022030501115573800_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/CLEP.S38850","article-title":"Cryptococcal meningitis: epidemiology and therapeutic options","volume":"6","author":"Sloan","year":"2014","journal-title":"Clin Epidemiology"},{"key":"2022030501115573800_bib3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2022030501115573800_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","article-title":"Cryptococcosis","volume":"30","author":"Maziarz","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"2022030501115573800_bib5","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1128\/AAC.06252-11","article-title":"Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine","volume":"56","author":"Espinel-Ingroff","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2022030501115573800_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10096-014-2289-2","article-title":"Molecular epidemiology of Cryptococcus neoformans and Cryptococcus gattii in China between 2007 and 2013 using multilocus sequence typing and the Diversilab system","volume":"34","author":"Dou","year":"2015","journal-title":"European J Clin Microbiol Infect Dis"},{"key":"2022030501115573800_bib7","doi-asserted-by":"crossref","first-page":"e72222","DOI":"10.1371\/journal.pone.0072222","article-title":"Geographically structured populations of Cryptococcus neoformans variety grubii in Asia correlate with HIV status and show a clonal population structure","volume":"8","author":"Khayhan","year":"2013","journal-title":"PLoS One"},{"key":"2022030501115573800_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/IDR.S57686","article-title":"Current trends in the prevalence of Cryptococcus gattii in the United States and Canada","volume":"8","author":"Espinel-Ingroff","year":"2015","journal-title":"Infect Drug Resistance"},{"key":"2022030501115573800_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11684-017-0601-0","article-title":"Epidemiology of fungal infections in China","volume":"12","author":"Chen","year":"2018","journal-title":"Front Med"},{"key":"2022030501115573800_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.fgb.2014.10.017","article-title":"Epidemiology of Cryptococcus and cryptococcosis in China","volume":"78","author":"Fang","year":"2015","journal-title":"Fungal Genet Biol"},{"key":"2022030501115573800_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2022030501115573800_bib12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/649861","article-title":"Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi","volume":"50","author":"Nussbaum","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2022030501115573800_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jinf.2011.10.014","article-title":"Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis","volume":"64","author":"Muzoora","year":"2012","journal-title":"J Infect"},{"key":"2022030501115573800_bib14","doi-asserted-by":"crossref","first-page":"e170391","DOI":"10.1590\/0074-02760170391","article-title":"The war on cryptococcosis: a review of the antifungal arsenal","volume":"113","author":"Mourad","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2022030501115573800_bib15","doi-asserted-by":"crossref","first-page":"3000605211016197","DOI":"10.1177\/03000605211016197","article-title":"Clinical characteristics, Cryptococcus neoformans genotypes, antifungal susceptibility, and outcomes in human immunodeficiency virus-positive patients in Beijing, China","volume":"49","author":"Xu","year":"2021","journal-title":"J International Med Res"},{"key":"2022030501115573800_bib16","doi-asserted-by":"crossref","first-page":"708280","DOI":"10.3389\/fmicb.2021.708280","article-title":"In vitro antifungal susceptibility profiles of Cryptococcus neoformans var. grubii and Cryptococcus gattii clinical isolates in Guangxi, Southern China","volume":"12","author":"Al-Odaini","year":"2021","journal-title":"Front Microbiol"},{"key":"2022030501115573800_bib17","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/JCM.43.5.2163-2167.2005","article-title":"Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)","volume":"43","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2022030501115573800_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/13693780802213407","article-title":"Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole","volume":"47","author":"Kantarcio\u011flu","year":"2009","journal-title":"Med Mycol"},{"key":"2022030501115573800_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0732-8893(00)00174-7","article-title":"Commercial systems for fluconazole susceptibility testing of yeasts: comparison with the broth microdilution method","volume":"38","author":"Posteraro","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2022030501115573800_bib20","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1128\/JCM.02316-09","article-title":"Comparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution reference methods and with the Sensititre Yeastone and Etest techniques for in vitro detection of antifungal resistance in yeast isolates","volume":"48","author":"Cuenca-Estrella","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2022030501115573800_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jac\/37.2.265","article-title":"Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique","volume":"37","author":"Chen","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"2022030501115573800_bib22","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/jcm.32.8.1992-1996.1994","article-title":"Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates","volume":"32","author":"Pfaller","year":"1994","journal-title":"J Clin Microbiol"},{"key":"2022030501115573800_bib23","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/jac\/46.6.997","article-title":"Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents","volume":"46","author":"Aller","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"2022030501115573800_bib24","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1128\/JCM.00952-10","article-title":"Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study","volume":"48","author":"Borghi","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2022030501115573800_bib25","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3109\/13693780903473343","article-title":"Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method","volume":"48","author":"Cejudo","year":"2010","journal-title":"Med Mycol"},{"key":"2022030501115573800_bib26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.diagmicrobio.2014.09.006","article-title":"Comparison of Etests and Vitek 2 \u00ae to broth microdilution for the susceptibility testing of Cryptococcus neoformans","volume":"80","author":"Mahabeer","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2022030501115573800_bib27","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/mmy\/myy150","article-title":"Comparative antifungal susceptibility analyses of Cryptococcus neoformans VN\u00a0\u2160 and Cryptococcus gattii VG\u00a0\u2161 from the Brazilian Amazon region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods","volume":"57","author":"Nishikawa","year":"2019","journal-title":"Med Mycol"},{"key":"2022030501115573800_bib28","doi-asserted-by":"crossref","first-page":"aac.02261","DOI":"10.1128\/AAC.02261-19","article-title":"Comparison of MIC test strip and Sensititre Yeastone with the CLSI and EUCAST broth microdilution reference methods for in vitro antifungal susceptibility testing of Cryptococcus neoformans","volume":"64","author":"Delma","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2022030501115573800_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1439-0507.1997.tb00179.x","article-title":"Comparison of broth macrodilution, broth microdilution and E-test susceptibility tests of Cryptococcus neoformans for fluconazole","volume":"40","author":"Chryssanthou","year":"1997","journal-title":"Mycoses"},{"key":"2022030501115573800_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10096-020-04013-4","article-title":"Molecular epidemiology and antifungal susceptibilities of Cryptococcus species isolates from HIV and non-HIV patients in Southwest China","volume":"40","author":"Wu","year":"2021","journal-title":"Europ J Clin Microbiol Infect Dis"},{"key":"2022030501115573800_bib31","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1128\/JCM.37.3.591-595.1999","article-title":"Multicenter comparison of the Sensititre Yeastone colorimetric antifungal panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms","volume":"37","author":"Espinel-Ingroff","year":"1999","journal-title":"J Clin Microbiol"},{"key":"2022030501115573800_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1099\/jmm.0.001101","article-title":"Molecular epidemiology and antifungal susceptibility profiles of clinical Cryptococcus neoformans\/Cryptococcus gattii species complex","volume":"69","author":"Bandalizadeh","year":"2020","journal-title":"J Med Microbiol"},{"key":"2022030501115573800_bib33","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1099\/jmm.0.029025-0","article-title":"In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India","volume":"60","author":"Chowdhary","year":"2011","journal-title":"J Med Microbiol"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myac009\/42339686\/myac009.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/60\/3\/myac009\/42745691\/myac009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/60\/3\/myac009\/42745691\/myac009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T01:12:26Z","timestamp":1646442746000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myac009\/6517704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myac009","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3]]},"published":{"date-parts":[[2022,1,31]]},"article-number":"myac009"}}